BerandaMNKD • NASDAQ
add
MannKind Corp
Tutup sebelumnya
$5,23
Rentang hari
$5,22 - $5,39
Rentang tahun
$3,39 - $7,62
Kapitalisasi pasar
1,63Â M USD
Volume Rata-Rata
4,50Â jt
Rasio P/E
49,60
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 76,53Â jt | 5,72% |
Biaya operasional | 45,30Â jt | 26,08% |
Laba bersih | 668,00Â rb | 133,17% |
Margin laba bersih | 0,87 | 131,29% |
Penghasilan per saham | 0,05 | — |
EBITDA | 12,75Â jt | -28,76% |
Tarif pajak efektif | 28,94% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 185,58Â jt | -26,66% |
Total aset | 411,70Â jt | -7,24% |
Total liabilitas | 466,74Â jt | -30,30% |
Total ekuitas | -55,04 jt | — |
Saham yang beredar | 306,83 jt | — |
Harga terhadap nilai buku | -29,06 | — |
Tingkat pengembalian aset | 6,49% | — |
Tingkat pengembalian modal | 27,72% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 668,00Â rb | 133,17% |
Kas dari operasi | 8,95Â jt | 133,50% |
Kas dari investasi | 6,26Â jt | 111,34% |
Kas dari pembiayaan | -5,51Â jt | 87,63% |
Perubahan kas bersih | 9,70Â jt | 110,11% |
Arus kas bebas | 251,38Â rb | -97,58% |
Tentang
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
MannKind Corporation was named after its founder, Alfred E. Mann. Wikipedia
Didirikan
Feb 1991
Kantor pusat
Situs
Karyawan
405
